Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 320-327

  Kamaraj, Sattu ^a   Anandakumar, Pandi ^a   Jagan, Sundaram ^a   Ramakrishnan, Gopalakrishnan ^a   Devaki, Thiruvengadam ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

COX 2 (cyclooxygenase 2); Hesperidin; Lung cancer; Mast cell density; MMP 2 (matrix metalloproteinase 2); MMP 9 (matrix metalloproteinase 9)

Indexed keywords

BENZO[A]PYRENE; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; HESPERIDIN; TOLONIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATTENUATION; CANCER INVASION; CELL ASSAY; CELL DENSITY; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZO(A)PYRENE; BLOTTING, WESTERN; CARCINOGENS; CELL COUNT; CYCLOOXYGENASE 2; DIETARY SUPPLEMENTS; DOWN-REGULATION; HESPERIDIN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MAST CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, SECRETED; MICE;

EID: 78049296495     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.017     Document Type: Article

References (65)

1. Anitha J., George T. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 2001, 7:14.
2. Ansorge S., Reinhold D., Lendeckel U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-beta1 production of human immune cells. Z. Naturforsch. C 2003, 58:580-589.
3. Balakrishnan A., Menon V.P. Effect of hesperidin on matrix metalloproteinases and antioxidant status during nicotine-induced toxicity. Toxicology 2007, 238:90-98.
4. Bernhard E.J., Gruber S.B., Muschel R.J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4293-4297.
5. Björklund M., Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. BBA-Reviews on Cancer 2005, 1755:37-69.
6. Brower G.L., Chancey A.L., Thanigaraj S., Matsubara B.B., Janicki J.S. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:518-525.
7. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999, 13:1382-1397.
8. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999, 13:1382-1397.
9. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103:481-490.
10. De Stefani E., Boffetta P., Deneo-Pellegrini H., Mendilaharsu M., Carzoglio J.C., Ronco A., Olivera L. Dietary antioxidants and lung cancer risk: a case-control study in Uruguay. Nutr. Cancer 1999, 34:100-110.
11. DuBois R.N., Shao J., Tsujii M., Sheng H., Beauchamp R.D. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res. 1996, 56:733-737.
12. Farias E., Ranuncolo S., Cresta C., Specterman S., Armanasco E., Varela M., Lastiri J., Pallotta M.G., Bal E., Joffe K. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int. J. Cancer (Pred. Oncol.) 2000, 89:389-394.
13. Fujiki H., Horiuchi T., Yamashita K., Hakii H., Suganuma M., Nishino H., Iwashima A., Hirata Y., Sugimura T. Inhibition of tumor promotion by flavonoids. Prog. Clin. Biol. Res. 1986, 213:429-440.
14. Galati E.M., Monforte M.T., Kirjavainen S., Forestieri A.M., Trovato A., Tripodo M.M. Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity. Farmaco 1994, 40:709-712.
15. Gounaris E., Erdman S.E., Restaino C., Gurish M.F., Friend D.S., Gounari F., Lee D.M., Zhang G., Glickman J.N., Shin K. Mast cells are an essential hematopoietic component for polyp development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:19977.
16. Hashimoto K., Kihira Y., Matuo Y., Usui T. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate. J. Urol. 1998, 160:1872-1876.
17. Hasturk S., Kemp B., Kalapurakal S.K., Kurie J.M., Hong W.K., Lee J.S. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer 2002, 94:1023-1031.
18. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst. 1999, 91:1194-1210.
19. Heissig B., Rafii S., Akiyama H., Ohki Y., Sato Y., Rafael T., Zhu Z., Hicklin D.J., Okumura K., Ogawa H., Werb Z., Hattori K. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J. Exp. Med. 2005, 202:739-750.
20. Hiratsuka S., Nakamura K., Iwai S., Murakami M., Itoh T., Kijima H., Shipley J.M., Senior R.M., Shibuya M. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2002, 2:289-300.
21. Hua Peng S., Deng H., Feng Yang J., Ping Xie P., Li C., Li H., Yun Feng D. Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J. Gastroenterol. 2005, 11:6521-6524.
22. Huang M.T., Wood A.W., Newmark H.L., Sayer J.M., Yagi H., Jerina D.M., Conney A.H. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis 1983, 4:1631-1637.
23. Kamaraj S., Ramakrishnan G., Anandakumar P., Jagan S., Devaki T. Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Invest New Drugs 2009, 27:214-222.
24. Kamaraj S., Vinodhkumar R., Anandakumar P., Jagan S., Ramakrishnan G., Devaki T. The effects of quercetin on antioxidant status and tumor markers in the lung and serum of mice treated with benzo(a)pyrene. Biol. Pharm. Bull. 2007, 30:2268-2273.
25. Kang Y., Prentice M.A., Mariano J.M., Davarya S., Linnoila R.I., Moody T.W., Wakefield L.M., Jakowlew S.B. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis. Exp. Lung Res. 2000, 26:685-707.
26. Koizumi K. Current surgical strategies for lung cancer with a focus on open thoracotomy and video-assisted thoracic surgery. J. Nippon Med. Sch. 2006, 73:116-121.
27. Kugler A., Hemmerlein B., Thelen P., Kallerhoff M., Radzun H.J., Ringert R.H. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J. Urol. 1998, 160:1914-1918.
28. Lampiasi N., Azzolina A., Montalto G., Cervello M. Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells. Exp. Mol. Med. 2007, 39:284-294.
29. Liotta L.A. Cancer cell invasion and metastasis. Sci. Am. 1992, 266:54-59.
30. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
31. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
32. Montanari A., Chen J., Widmer W. Citrus flavonoids: a review of past biological activity against disease. Discovery of new flavonoids from Dancy tangerine cold pressed peel oil solids and leaves. Adv Exp Med Biol 1998, 439:103-116.
33. Nyberg F., Agrenius V., Svartengren K., Svensson C., Pershagen G. Dietary factors and risk of lung cancer in never-smokers. Int. J. Cancer 1998, 78:430-436.
34. Ochiai M., Oguri T., Isobe T., Ishioka S., Yamakido M. Cyclooxygenase-2 (COX-2) mRNA expression levels in normal lung tissues and non-small cell lung cancers. Jpn J. Cancer Res. 1999, 90:1338-1343.
35. Osborn M.R., Beland F.A., Harvey R.G., Brookes P. The reaction of BaPDE with DNA. Int. J. Cancer 1976, 18:362-368.
36. Prosperi J.R., Mallery S.R., Kigerl K.A., Erfurt A.A., Robertson F.M. Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2. Prostaglandins Other Lipid Mediat. 2004, 73:249-264.
37. Ranieri G., Labriola A., Achille G., Florio G., Zito A.F., Grammatica L., Paradiso A. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int. J. Oncol. 2002, 21:1317-1323.
38. Ratty A.K., Das N.P. Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem. Med. Metab. Biol. 1988, 39:69-79.
39. Ruano-Ravina A., Figueiras A., Montes-Martínez A., Barros-Dios J.M. Dose-response relationship between tobacco and lung cancer: new findings. Eur. J. Cancer Prev. 2003, 12:257.
40. Sakata K., Hirose Y., Qiao Z., Tanaka T., Mori H. Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. Cancer Lett. 2003, 199:139-145.
41. Sandler A.B., Dubinett S.M. COX-2 inhibition and lung cancer. Semin. Oncol. 2004, 31:45-52.
42. Sauer C.G., Kappeler A., Spath M., Kaden J.J., Michel M.S., Mayer D., Bleyl U., Grobholz R. Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients. Virchows Arch. 2004, 444:518-526.
43. Speizer F.E., Colditz G.A., Hunter D.J., Rosner B., Hennekens C. Prospective study of smoking, antioxidant intake, and lung cancer in middle-aged women (USA). Cancer Causes Control 1999, 10:475-482.
44. Stetler-Stevenson W.G. The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis. Surg. Oncol. Clin. N. Am. 2001, 10:383-392.
45. Takanami I., Takeuchi K., Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000, 88:2686-2692.
46. Tang T.C., Poon R.T., Lau C.P. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J. Gastroenterol. 2005, 11:1896-1902.
47. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 2005, 280:9291.
48. Thatcher N. Integrating new targeted agents into the treatment of non-small-cell lung cancer. Lung Cancer 2006, 54(Suppl 2):S25-S31.
49. Tian Q., Miller E.G., Ahmad H., Tang L., Patil B.S. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr. Cancer 2001, 40:180-184.
50. Tomita M., Matsuzaki Y., Onitsuka T. Effect of mast cells on tumor angiogenesis in lung cancer. Soc Thorac Surgeons 2000, 1686-1690.
51. Toth-Jakatics R., Jimi S., Takebayashi S., Kawamoto N. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum. Pathol. 2000, 31:955-960.
52. Tsatsanis C., Androulidaki A., Venihaki M., Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 2006, 38:1654-1661.
53. Tsujii M., DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83:493-501.
54. Uchima Y., Sawada T., Hirakawa K. Action of antiproteases on pancreatic cancer cells. JOP. J Pancreas (Online) 2007, 8:479-487.
55. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2046-2050.
56. Vinodhkumar R., Song Y.S., Ravikumar V., Ramakrishnan G., Devaki T. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549). Chem.-Biol. Interact. 2007, 165:220-229.
57. Voorrips L.E., Goldbohm R.A., Verhoeven D.T.H., van Poppel G., Sturmans F., Hermus R.J.J., van den Brandt P.A. Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on Diet and Cancer. Cancer Causes Control 2000, 11:101-115.
58. Weiss L. Metastatic inefficiency. Adv. Cancer Res. 1990, 54:159-211.
59. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
60. Winawer S., Fletcher R., Rex D., Bond J., Burt R., Ferrucci J., Ganiats T., Levin T., Woolf S., Johnson D., Kirk L., Litin S., Simmang C. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544-560.
61. Winterhalder R.C., Hirsch F.R., Kotantoulas G.K., Franklin W.A., Bunn P.A. Chemoprevention of lung cancer-from biology to clinical reality. Ann. Oncol. 2004, 15:185.
62. Yang S.F., Hsieh Y.S., Lin C.L., Hsu N.Y., Chiou H.L., Chou F.P., Chu S.C. Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. Clin. Chim. Acta 2005, 354:91-99.
63. Yong L.C., Brown C.C., Schatzkin A., Dresser C.M., Slesinski M.J., Cox C.S., Taylor P.R. Intake of vitamins E, C, and A and risk of lung cancer: the NHANES I Epidemiologic Followup Study. Am. J. Epidemiol. 1997, 146:231-243.
64. Yoon S.O., Park S.J., Yun C.H., Chung A.S. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J. Biochem. Mol. Biol. 2003, 36:128-137.
65. Zhu Y.M., Azahri N.S., Yu D.C., Woll P.J. Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 2008, 8:218.